Unclaimed brand
Leading non-profit organisation advancing psychedelic research and therapy in Europe. We organize international conferences, networking events, and masterclasses, train licensed therapists, and connect professionals and experts in science, therapy, policy and implementation. Our primary aim is to ensure that insights from psychedelic research contribute to better treatments in mental health care, and to safeguard the sustainable, responsible and safe integration of psychedelic therapy in mainstream care and society at large.
Liking this brand profile? Share this page
Hex Code
Color name
RGB
HSL
CMYK
#93215A
Disco
147, 33, 90
330, 63, 35
0, 78, 39, 42
#6BA3BC
Glacier
107, 163, 188
199, 38, 58
43, 13, 0, 26
#2F444E
Pickled Bluewood
47, 68, 78
199, 25, 25
40, 13, 0, 69
The OPEN Foundation is a Dutch nonprofit advancing psychedelic research and therapy for the benefit of science, healthcare, and society. Founded in 2007, it promotes rigorous, interdisciplinary research and supports the safe, ethical, and responsible integration of beneficial psychedelic therapies into mainstream care and society. The foundation connects researchers, clinicians, policymakers, and other professionals through international conferences, networking opportunities, and educational events. Its flagship event, the Interdisciplinary Conference on Psychedelic Research (ICPR), brings together experts to share developments in psychedelic science and therapy.
Through OPEN Academy, the foundation provides therapist education, including ADEPT, a two-year hybrid programme, and Foundations, a 13-month online programme. Other offerings include short courses, workshops, masterclasses, supervision groups, and online community events. OPEN also shares research, articles, talks, and curated news, while collaborating on research initiatives such as PsyPal, focused on psilocybin therapy for psychological distress in palliative care. By building professional communities and engaging with policymakers, the OPEN Foundation works to help ensure that advances in psychedelic research contribute responsibly to mental healthcare.
